Evaluate the Treatment With Sintilimab Injection Plus Endostar in Hepatocellular Carcinoma

Condition:   Hepatocellular Carcinoma Non-resectable Intervention:   Sponsor:   Huazhong University of Science and Technology Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials